Oramed Pharmaceuticals Competitors and Similar CompaniesClear all
Oramed Pharmaceuticals's competitors and similar companies include Rani Therapeutics, Larimar Therapeutics, Diapin Therapeutics and Kowa Pharmaceuticals America.
 Oramed Pharmaceuticals Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies. |  Rani Therapeutics Rani Therapeutics Holdings is a clinical-stage biotherapeutics company developing technologies for orally administered biologics. |  Larimar Therapeutics Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders. |  Diapin Therapeutics Diapin Therapeutics is a biotech company focused on the treatment of Type 2 diabetes. |  Kowa Pharmaceuticals America Kowa Pharmaceuticals America is a pharmaceutical company focused on cardiometabolic diseases. | |
Founding Date | Founding Date 2006 | Founding Date 2012 | Founding Date 2005 | Founding Date 2011 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations New York, US HQ Jerusalem, IL | Locations San Jose, US HQ | Locations Bala Cynwyd, US HQ | Locations Ann Arbor, US HQ | Locations Montgomery, US HQ |
Employees | Employees 1417% increase | Employees 71 | Employees 782% decrease | Employees 5 | Employees 3521% increase |
Valuation ($) | Valuation ($) 94.2 m | Valuation ($) 135.4 m | Valuation ($) 496.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $2m (FY, 2025) | Revenue (est.) $1.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income $64m (FY, 2025) | Net income ($41m) (FY, 2025) | Net income ($165.7m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1m | Total funding raised $ 176.5m | Total funding raised $ 132.2m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Rani Therapeutics
HQ
San Jose, US
Employees
71
Rani Therapeutics Holdings is a clinical-stage biotherapeutics company developing technologies for orally administered biologics.
View companyLarimar Therapeutics
HQ
Bala Cynwyd, US
Employees
7
Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders.
View companyDiapin Therapeutics
HQ
Ann Arbor, US
Employees
5
Diapin Therapeutics is a biotech company focused on the treatment of Type 2 diabetes.
View companyKowa Pharmaceuticals America
HQ
Montgomery, US
Kowa Pharmaceuticals America is a pharmaceutical company focused on cardiometabolic diseases.
View company